Vangjeli Ciara, Clarke Niamh, Quinn Ursula, Dicker Patrick, Tighe Orna, Ho Clara, O'Brien Eoin, Stanton Alice V
Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Belfield, Dublin, Ireland.
Circ Cardiovasc Genet. 2010 Feb;3(1):53-9. doi: 10.1161/CIRCGENETICS.109.899930. Epub 2009 Dec 30.
Studies of knockout and transgenic mice have demonstrated key roles for genes encoding components of the renin angiotensin system in blood pressure regulation. However, whether polymorphisms in these genes contribute to the cause of essential hypertension in humans is still a matter of debate.
We performed an experiment with dense tagging single-nucleotide polymorphism coverage of 4 genes encoding proteins that control the overall activity of the cascade, namely renin, angiotensinogen, angiotensin-converting enzyme, and angiotensin-converting enzyme 2, in 2 Irish populations. Both clinic and 24-hour ambulatory blood pressure measurements were available from population I (n=387), whereas just clinic blood pressure was measured in population II (n=1024). Of the 23 polymorphisms genotyped, only a single renin gene polymorphism, REN-5312C/T, showed consistent statistically significant associations with elevated diastolic pressures. Carriage of one REN-5312T allele was associated with the following age- and sex-adjusted increments in diastolic pressures (mean [95% CI]): population I, clinic, 1.5 mm Hg (0.3 to 2.8); daytime, 1.4 mm Hg (0.4 to 2.4); night-time, 1.3 mm Hg (0.4 to 2.3), and population II, clinic, 1.1 mm Hg (0.1 to 2.1). Haplotypic analyses and multivariate stepwise regression analyses were in concordance with individual single-nucleotide polymorphism analyses.
The REN-5312T allele had been shown previously to result in increased in vitro expression of the renin gene. We have now shown, in 2 independent populations, that carriage of a REN-5312T allele is associated with elevated diastolic blood pressure. These data provide evidence that renin is an important susceptibility gene for arterial hypertension in whites.
对基因敲除和转基因小鼠的研究已证明,编码肾素血管紧张素系统组分的基因在血压调节中起关键作用。然而,这些基因中的多态性是否会导致人类原发性高血压的病因仍存在争议。
我们在两个爱尔兰人群中进行了一项实验,对4个编码控制该级联反应整体活性的蛋白质的基因(即肾素、血管紧张素原、血管紧张素转换酶和血管紧张素转换酶2)进行了密集标记单核苷酸多态性覆盖。人群I(n = 387)提供了临床和24小时动态血压测量数据,而人群II(n = 1024)仅测量了临床血压。在23个基因分型的多态性中,只有一个肾素基因多态性REN-5312C/T与舒张压升高呈现出一致的统计学显著关联。携带一个REN-5312T等位基因与以下经年龄和性别调整后的舒张压升高相关(均值[95%可信区间]):人群I,临床,1.5 mmHg(0.3至2.8);日间,1.4 mmHg(0.4至2.4);夜间,1.3 mmHg(0.4至2.3),以及人群II,临床,1.1 mmHg(0.1至2.1)。单倍型分析和多变量逐步回归分析与单个单核苷酸多态性分析结果一致。
先前已表明,REN-5312T等位基因会导致肾素基因在体外表达增加。我们现在在两个独立人群中表明,携带REN-5312T等位基因与舒张压升高相关。这些数据提供了证据,表明肾素是白人动脉高血压的一个重要易感基因。